Log in or Sign up for Free to view tailored content for your specialty!
May 19, 2026
2 min read
Save
Epioxa significantly slows keratoconus progression over 12 months
Find the latest Cornea and External Disease and Ophthalmology news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.
Log in or Sign up for Free to view tailored content for your specialty!
May 19, 2026
2 min read
Save
Epioxa significantly slows keratoconus progression over 12 months

Epioxa, an epithelium-on corneal collagen cross-linking therapy, made a significant and clinically meaningful difference in…

Find the latest Cornea and External Disease and Optometry news articles, videos, podcasts, and meeting coverage from medical…

An epithelium-off corneal cross-linking treatment has been approved in the U.S. for nearly a decade.During that time, we have…

Epioxa obtained FDA approval in October 2025, which makes it the first and only FDA-approved epithelium-on, oxygen-enriched…

Epioxa improved corneal curvature and demonstrated visual acuity gains and safety in pediatric patients with keratoconus,…

KIAWAH ISLAND, S.C. — In this video from Kiawah Eye & Retina, Beeran B. Meghpara, MD, highlights the benefits of Epioxa from…